Castle Biosciences (CSTL): Director sold ~$64K
Derek J Maetzold, Director at Castle Biosciences, sold ~$64K of Castle Biosciences shares.
- ~$64K
- Approx. value · 1,972 sh @ $32.27
- 92K
- Holds after · shares reported
- Traded
- Oct 14, 2024
- Filed
- Oct 16, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 4, 2024Insider · 1 personInsiders: 7 sales (~$74K)
- Oct 7, 2024Insider · 1 personInsiders: 3 sales (~$232K)
- Oct 8, 2024Insider · 1 personInsiders: 7 sales (~$78K)
- Oct 14, 2024 · this disclosureInsiderDirector sold ~$64K of CSTL shares in the open market
What came next
- Oct 14, 2024Insider · 1 personInsiders: 6 sales (~$102K)
- Nov 1, 2024Insider · 2 peopleInsiders: 10 sales (~$383K)
- Nov 4, 2024Insider · 1 personInsiders: 14 sales (~$167K)
- Nov 5, 2024InsiderOfficer sold ~$125K of CSTL shares in the open market
- Nov 12, 2024Insider · 1 personInsiders: 7 sales (~$175K)
- Nov 15, 2024Insider · 1 personInsiders: 2 sales (~$207K)
- Dec 3, 2024Insider · 1 personInsiders: 6 sales (~$244K)
- Dec 5, 2024Insider · 1 personInsiders: 7 sales (~$161K)
- Dec 13, 2024Insider · 1 personInsiders: 9 sales (~$424K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Castle Biosciences
For Castle Biosciences, OQRO holds 31 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CSTL page.
Other recent filings by Derek J Maetzold, Pres. & Chief Exec. Officer
- SEC Form 4 at Castle Biosciences (CSTL)Nov 4, 2026
- SEC Form 4 at Castle Biosciences (CSTL)Nov 4, 2026
- SEC Form 4 at Castle Biosciences (CSTL)Nov 4, 2026
- SEC Form 4 at Castle Biosciences (CSTL)Nov 4, 2026
- SEC Form 4 at Castle Biosciences (CSTL)Nov 4, 2026
The full history of Derek J Maetzold, Pres. & Chief Exec. Officer is on the profile page.
How this filing works
Explore the data
Other disclosures at Castle Biosciences
- SEC Form 4Nov 13, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 4Nov 4, 2026
Everything OQRO holds on this company is on its CSTL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
